Apararenone in patients with diabetic nephropathy: results of a randomized, double-blind, placebo-controlled phase 2 dose–response study and open-label extension study

被引：0
|
作者：
Takashi Wada
Masaya Inagaki
Toru Yoshinari
Ryuji Terata
Naoko Totsuka
Miki Gotou
Gaia Hashimoto
机构：
[1] Kanazawa University,Department of Nephrology and Laboratory Medicine
[2] Mitsubishi Tanabe Pharma Corporation,Data Science Department, Ikuyaku. Integrated Value Development Division
[3] Mitsubishi Tanabe Pharma Corporation,Clinical Research and Development II Department, Ikuyaku. Integrated Value Development Division
来源：
Clinical and Experimental Nephrology | 2021年 / 25卷
关键词：
Diabetic nephropathy; Diabetic kidney disease; Dose-finding study; Fibrosis; Mineralocorticoid receptor antagonists; Apararenone;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：120 / 130
页数：10
相关论文
共 50 条
  • [31] Efficacy and Tolerability of Elamipretide in Patients With Barth Syndrome: Results From Tazpower, a Randomized, Double-Blind, Placebo-Controlled, Crossover and Open-Label Extension Trial
    Vernon, Hilary J.
    Thompson, WIlliam R.
    Aiudi, Anthony
    Jones, John J.
    Carr, Jim
    Hornby, Brittany DeCroes
    CIRCULATION, 2019, 140
  • [32] Assessment of Denosumab in Korean Postmenopausal Women with Osteoporosis: Randomized, Double-Blind, Placebo-Controlled Trial with Open-Label Extension
    Koh, Jung-Min
    Chung, Dong Jin
    Chung, Yoon-Sok
    Kang, Moo-Il
    Kim, In-Ju
    Min, Yong-Ki
    Oh, Han-Jin
    Park, Il Hyung
    Lee, Yil-Seob
    Kravitz, Barbara
    Waterhouse, Brian
    Nino, Antonio
    Fitzpatrick, Lorraine A.
    YONSEI MEDICAL JOURNAL, 2016, 57 (04) : 905 - 914
  • [33] Adjunctive zonisamide therapy in the long-term treatment of children with partial epilepsy: Results of an open-label extension study of a phase III, randomized, double-blind, placebo-controlled trial
    Guerrini, Renzo
    Rosati, Anna
    Bradshaw, Kate
    Giorgi, Luigi
    EPILEPSIA, 2014, 55 (04) : 568 - 578
  • [34] EFFECTS OF ADD-ON MIRTAZAPINE ON NEUROCOGNITION IN SCHIZOPHRENIA: AN OPEN LABEL EXTENSION PHASE OF A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY, AND BOTH PHASES
    Stenberg, Jan H.
    Terevnikov, Viacheslav
    Joffe, Marina
    Tiihonen, Jari
    Tchoukhine, Evgueni
    Burkin, Mark
    Joffe, Grigori
    SCHIZOPHRENIA RESEARCH, 2010, 117 (2-3) : 377 - 377
  • [35] Hexasodium fytate for the treatment of calciphylaxis: a randomised, double-blind, phase 3, placebo-controlled trial with an open-label extension
    Sinha, Smeeta
    Nigwekar, Sagar U.
    Brandenburg, Vincent
    Gould, Lisa J.
    Serena, Thomas E.
    Moe, Sharon M.
    Aronoff, George R.
    Chatoth, Dinesh K.
    Hymes, Jeffrey L.
    Carroll, Kevin J.
    Alperovich, Gabriela
    Keller, Laurence H.
    Perello, Joan
    Gold, Alex
    Chertow, Glenn M.
    ECLINICALMEDICINE, 2024, 75
  • [36] Upadacitinib in active ankylosing spondylitis: results of the 2-year, double-blind, placebo-controlled SELECT-AXIS 1 study and open-label extension
    van der Heijde, Desiree
    Deodhar, Atul
    Maksymowych, Walter P.
    Sieper, Joachim
    Van den Bosch, Filip
    Kim, Tae-Hwan
    Kishimoto, Mitsumasa
    Ostor, Andrew J.
    Combe, Bernard
    Sui, Yunxia
    Duan, Yuanyuan
    Wung, Peter K.
    Song, In-Ho
    RMD OPEN, 2022, 8 (02):
  • [37] Repaglinide in type 2 diabetes: A randomized, double-blind, placebo-controlled, dose-response study
    Schwartz, SL
    Goldberg, RB
    Strange, P
    DIABETES, 1998, 47 : A98 - A98
  • [38] Commentary on "Efficacy and Safety of PrabotulinumtoxinA in Subjects With Benign Masseteric Hypertrophy: A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase 3 Trial and Open-Label Extension Study"
    Hausauer, Amelia K.
    DERMATOLOGIC SURGERY, 2024, 50 (06) : 534 - 534
  • [39] Clinical response to alimumab treatment in patients with moderate to severe psoriasis: Double-blind, randomized controlled trial and open-label extension study
    Gordon, Kenneth B.
    Langley, Richard G.
    Leonardi, Craig
    Toth, Darryl
    Menter, M. Alan
    Kang, Sewon
    Heffernan, Michael
    Miller, Bruce
    Hamlin, Regina
    Lim, Liberata
    Zhong, Jianhua
    Hoffman, Rebecca
    Okun, Martin M.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 55 (04) : 598 - 606
  • [40] Effect of rosuvastatin on diabetic polyneuropathy: a randomized, double-blind, placebo-controlled Phase IIa study
    Hernandez-Ojeda, Jaime
    Miguel Roman-Pintos, Luis
    Daniel Rodriguez-Carrizalez, Adolfo
    Troyo-Sanroman, Rogelio
    German Cardona-Munoz, Ernesto
    del Pilar Alatorre-Carranza, Maria
    Guillermina Miranda-Diaz, Alejandra
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2014, 7 : 401 - 407
12345